The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy

Lisa M Rimsza, David S. Viswanatha, Stuart S. Winter, Catherine P. Leith, Jami D. Frost, Kathy Foucar

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Early detection of relapse in children with acute lymphoblastic leukemia (ALL), as well as distinction of leukemic blasts from hematogones, can be difficult by morphologic examination alone. Using CD34 and terminal deoxynucleotidyl transferase (TdT) immunoperoxidase stains, we studied specimens from 25 children with ALL in morphologic remission to determine if we could identify children at risk of relapse. We studied morphologic remission bone marrow specimens from 9 patients who experienced relapse during the subsequent 6 months and 16 children who remained in complete remission, including 10 specimens with increased numbers of hematogones. Despite morphologic remission, clusters of more than 5 CD34+ and/or TdT- positive cells were identified before overt relapse in 6 of 9 cases of relapse, but were noted in only 1 of 10 specimens from children in continuous complete remission and none of l O specimens with increased numbers of hematogones. Clusters of CD34+ or TdT-positive cells can identify individual patients at risk for imminent relapse. Hematogones may be differentiated from lymphoblasts by this method.

Original languageEnglish (US)
Pages (from-to)313-320
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume110
Issue number3
StatePublished - Sep 1998
Externally publishedYes

Fingerprint

Maintenance Chemotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
DNA Nucleotidylexotransferase
Coloring Agents
Bone Marrow

Keywords

  • Acute lymphobtastic leukemia
  • CD34
  • Hematogones
  • Immunoperoxidase
  • Relapse
  • TdT
  • Terminal deoxynucleotidyl transferase

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. / Rimsza, Lisa M; Viswanatha, David S.; Winter, Stuart S.; Leith, Catherine P.; Frost, Jami D.; Foucar, Kathy.

In: American Journal of Clinical Pathology, Vol. 110, No. 3, 09.1998, p. 313-320.

Research output: Contribution to journalArticle

Rimsza, Lisa M ; Viswanatha, David S. ; Winter, Stuart S. ; Leith, Catherine P. ; Frost, Jami D. ; Foucar, Kathy. / The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. In: American Journal of Clinical Pathology. 1998 ; Vol. 110, No. 3. pp. 313-320.
@article{1b86725b9e84422b9d29cd22b08280c7,
title = "The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy",
abstract = "Early detection of relapse in children with acute lymphoblastic leukemia (ALL), as well as distinction of leukemic blasts from hematogones, can be difficult by morphologic examination alone. Using CD34 and terminal deoxynucleotidyl transferase (TdT) immunoperoxidase stains, we studied specimens from 25 children with ALL in morphologic remission to determine if we could identify children at risk of relapse. We studied morphologic remission bone marrow specimens from 9 patients who experienced relapse during the subsequent 6 months and 16 children who remained in complete remission, including 10 specimens with increased numbers of hematogones. Despite morphologic remission, clusters of more than 5 CD34+ and/or TdT- positive cells were identified before overt relapse in 6 of 9 cases of relapse, but were noted in only 1 of 10 specimens from children in continuous complete remission and none of l O specimens with increased numbers of hematogones. Clusters of CD34+ or TdT-positive cells can identify individual patients at risk for imminent relapse. Hematogones may be differentiated from lymphoblasts by this method.",
keywords = "Acute lymphobtastic leukemia, CD34, Hematogones, Immunoperoxidase, Relapse, TdT, Terminal deoxynucleotidyl transferase",
author = "Rimsza, {Lisa M} and Viswanatha, {David S.} and Winter, {Stuart S.} and Leith, {Catherine P.} and Frost, {Jami D.} and Kathy Foucar",
year = "1998",
month = "9",
language = "English (US)",
volume = "110",
pages = "313--320",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

TY - JOUR

T1 - The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy

AU - Rimsza, Lisa M

AU - Viswanatha, David S.

AU - Winter, Stuart S.

AU - Leith, Catherine P.

AU - Frost, Jami D.

AU - Foucar, Kathy

PY - 1998/9

Y1 - 1998/9

N2 - Early detection of relapse in children with acute lymphoblastic leukemia (ALL), as well as distinction of leukemic blasts from hematogones, can be difficult by morphologic examination alone. Using CD34 and terminal deoxynucleotidyl transferase (TdT) immunoperoxidase stains, we studied specimens from 25 children with ALL in morphologic remission to determine if we could identify children at risk of relapse. We studied morphologic remission bone marrow specimens from 9 patients who experienced relapse during the subsequent 6 months and 16 children who remained in complete remission, including 10 specimens with increased numbers of hematogones. Despite morphologic remission, clusters of more than 5 CD34+ and/or TdT- positive cells were identified before overt relapse in 6 of 9 cases of relapse, but were noted in only 1 of 10 specimens from children in continuous complete remission and none of l O specimens with increased numbers of hematogones. Clusters of CD34+ or TdT-positive cells can identify individual patients at risk for imminent relapse. Hematogones may be differentiated from lymphoblasts by this method.

AB - Early detection of relapse in children with acute lymphoblastic leukemia (ALL), as well as distinction of leukemic blasts from hematogones, can be difficult by morphologic examination alone. Using CD34 and terminal deoxynucleotidyl transferase (TdT) immunoperoxidase stains, we studied specimens from 25 children with ALL in morphologic remission to determine if we could identify children at risk of relapse. We studied morphologic remission bone marrow specimens from 9 patients who experienced relapse during the subsequent 6 months and 16 children who remained in complete remission, including 10 specimens with increased numbers of hematogones. Despite morphologic remission, clusters of more than 5 CD34+ and/or TdT- positive cells were identified before overt relapse in 6 of 9 cases of relapse, but were noted in only 1 of 10 specimens from children in continuous complete remission and none of l O specimens with increased numbers of hematogones. Clusters of CD34+ or TdT-positive cells can identify individual patients at risk for imminent relapse. Hematogones may be differentiated from lymphoblasts by this method.

KW - Acute lymphobtastic leukemia

KW - CD34

KW - Hematogones

KW - Immunoperoxidase

KW - Relapse

KW - TdT

KW - Terminal deoxynucleotidyl transferase

UR - http://www.scopus.com/inward/record.url?scp=0031722954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031722954&partnerID=8YFLogxK

M3 - Article

C2 - 9728605

AN - SCOPUS:0031722954

VL - 110

SP - 313

EP - 320

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -